Structure Therapeutics Inc.
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Nov 4, 2026 (9 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 9, 2026 | Citizens | reiterate | Market Outperform → Market Outperform | — | 47% |
| Aug 7, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Aug 7, 2026 | Citizens | maintain | Market Outperform → Market Outperform | — | 47% |
| Jun 11, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Apr 27, 2026 | Canaccord Genuity | initiate | — → Buy | — | 48% |
| Mar 16, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Mar 2, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Feb 27, 2026 | Citizens | maintain | Market Outperform → Market Outperform | $113 | 47% |
| Jan 22, 2026 | JP Morgan | maintain | Overweight → Overweight | $105 | 54% |
| Jan 20, 2026 | Guggenheim | maintain | Buy → Buy | $140 | 52% |
| Dec 19, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $90 | 44% |
| Dec 12, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $125 | 54% |
| Dec 12, 2025 | Citizens | maintain | Market Outperform → Market Outperform | $120 | 47% |
| Dec 11, 2025 | Jefferies | maintain | Buy → Buy | $125 | 52% |
| Dec 9, 2025 | Citigroup | maintain | Buy → Buy | $100 | 54% |
| Dec 9, 2025 | Stifel | maintain | Buy → Buy | $90 | 53% |
| Dec 9, 2025 | Clear Street | maintain | Buy → Buy | $99 | 48% |
| Aug 7, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $60 | 44% |
| Aug 7, 2025 | Guggenheim | maintain | Buy → Buy | $90 | 52% |
| Aug 7, 2025 | JMP Securities | maintain | Market Outperform → Market Outperform | $87 | 53% |
| Jun 23, 2025 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $65 | 50% |
| Jun 23, 2025 | JMP Securities | reiterate | Market Outperform → Market Outperform | $89 | 53% |
| May 12, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $75 | 44% |
| May 2, 2025 | Citigroup | initiate | — → Buy | $60 | 54% |
| Apr 22, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $80 | 44% |
| Feb 28, 2025 | Citizens Capital Markets | maintain | Market Outperform → Market Outperform | $87 | 49% |
| Feb 28, 2025 | William Blair | initiate | — → Outperform | $0 | 48% |
| Jan 8, 2025 | Stifel | initiate | — → Buy | $50 | 53% |
| Dec 20, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $80 | 44% |
| Dec 19, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $80 | 44% |
| Dec 18, 2024 | JMP Securities | reiterate | Market Outperform → Market Outperform | $91 | 53% |
| Dec 4, 2024 | HC Wainwright & Co. | initiate | — → Buy | $80 | 44% |
| Sep 23, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $65 | 50% |
| Sep 23, 2024 | Morgan Stanley | initiate | — → Overweight | $118 | 54% |
| Sep 16, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $65 | 50% |
| Sep 9, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $65 | 50% |
| Aug 19, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $65 | 50% |
| Aug 15, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $65 | 50% |
| Aug 9, 2024 | JMP Securities | maintain | Market Outperform → Market Outperform | $86 | 53% |
| Jul 1, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $65 | 50% |
| Jun 20, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $65 | 50% |
| Jun 17, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $65 | 50% |
| Jun 7, 2024 | BMO Capital | maintain | Outperform → Outperform | $100 | 53% |
| Jun 3, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $65 | 50% |
| May 21, 2024 | JP Morgan | initiate | — → Overweight | $65 | 54% |
| May 10, 2024 | JMP Securities | reiterate | Market Outperform → Market Outperform | $91 | 53% |
| May 3, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $65 | 50% |
| Apr 18, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $65 | 50% |
| Apr 9, 2024 | Cantor Fitzgerald | initiate | — → Overweight | $65 | 50% |
| Mar 8, 2024 | JMP Securities | reiterate | Market Outperform → Market Outperform | $91 | 53% |
No cross-platform signals in the last 90 days